Asunto(s)
Encopresis/diagnóstico , Encopresis/terapia , Distribución por Edad , Causalidad , Niño , Preescolar , Comorbilidad , Estreñimiento/epidemiología , Diagnóstico Diferencial , Encopresis/epidemiología , Incontinencia Fecal/epidemiología , Enfermedad de Hirschsprung/diagnóstico , Humanos , Hipoparatiroidismo/diagnóstico , Hipotiroidismo/diagnóstico , Masculino , Anamnesis , Examen Físico/métodos , Control de EsfínteresRESUMEN
OBJECTIVE: The primary aim of this study was to determine if there is a change in the quality of life in pediatric patients with unremitting functional constipation and/or encopresis after undergoing a MACE procedure. METHODS: Patients, ages 5 to 18 years with unremitting constipation and a normal evaluation, including anorectal manometry and colonic manometry, who opted to undergo a MACE procedure were contacted to participate in the study. Patients with congenital anorectal malformations as well as spinal cord disorders were excluded from the study. The patient's parent/guardian completed the PedsQL(TM) Generic Core Scales QOL survey prior to the operation, 6 months, and 12 months after the procedure. RESULTS: A total of 15 consecutive patients meeting protocol criteria were recruited within a period of 20 months. The mean age at the MACE procedure was 9.8 years (range 7.0-11.1). 5 patients were female. The mean QOL score pre-MACE was 64.1. At 6 months post-MACE the mean overall QOL score was 90.2, and it was 92.0 at 12 months. All 15 patients at the 6 month follow up had significant improvement in their QOL (p=1.9 × 10(-7)) and all subcategories of QOL were significantly improved as well. CONCLUSIONS: A MACE procedure is of benefit to otherwise normal pediatric patients who have unremitting functional constipation with failure of medical treatment. Our patients had a significant improvement in all QOL categories and overall QOL.